EVFM — Evofem Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Evofem Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3.42	1.33	23.8	48.9	7.73
Net Total Accounts Receivable
Net Total Receivables	—	0.449	0.686	1.32	6.45
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.03	2.48	26.4	97.7	30.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0.593	0.554	11.2	11.2
Long Term Notes Receivable
Other Long Term Assets
Total Assets	4.12	4.01	28.3	110	42.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.41	27.3	12.7	77.3	138
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1.41	27.4	12.7	109	142
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2.71	-23.4	15.6	1.35	-99.6
Total Liabilities & Shareholders' Equity	4.12	4.01	28.3	110	42.5
Total Common Shares Outstanding
Total Preferred Shares Outstanding

Discover the metrics influencing Evofem Biosciences's share price